Remedy Biologics

Deciphering Immune Biology

Dublin, Ireland · $11.7M raised

Headquarters
Dublin
Employees
11–50
Business Model
B2B
Total Funding
$11.7M
Last Round
$11.7M GrantJul 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Based in Dublin, Remedy Biologics (RemedyBio) is a nanoscale biotechnology company pioneering ultra-high-throughput therapeutic discovery. It maps the function of cells directly from patient biology to harness the human immune system against disease, with an initial focus on a Rapid COVID-19 Passive Therapy Response Platform. The company has formed a research and evaluation agreement with GSK and completed a €10.5M financing round from the European Innovation Council.

Summary

Remedy Biologics is a Biotech company based in Dublin, Ireland. It has raised $11.7M in total across 1 round, most recently a $11.7M Grant round in Jul 2021. Investors include European Innovation Council Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJul 2021
$11.7M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Remedy Biologics on Indexed.vc
<a href="https://indexed.vc/companies/remedy-biologics"><img src="https://indexed.vc/api/badge/company/remedy-biologics" alt="Remedy Biologics on Indexed.vc" width="260" height="76" /></a>